Risk of lymphadenopathy from SARS-CoV-2 vaccination: a self-controlled case series analysis
Description
CONCLUSION: SARS-CoV-2 vaccination is associated with a statistically significant increase in the risk of lymphadenopathy, and this risk was observed only with mRNA vaccines.
